A carregar...

Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study

Background and aims: Administration of interferon (IFN)-β may represent a rational approach to the treatment of ulcerative colitis through its immunomodulatory and anti-inflammatory effects. The present study was performed to evaluate the efficacy and tolerability of IFN-β-1a. Methods: Patients (n=1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nikolaus, S, Rutgeerts, P, Fedorak, R, Steinhart, A H, Wild, G E, Theuer, D, Möhrle, J, Schreiber, S
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2003 by Gut 2003
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773804/
https://ncbi.nlm.nih.gov/pubmed/12912859
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!